1. Home
  2. MRVI
  3. MRVI News

Latest Maravai LifeSciences Holdings Inc. (MRVI) News on February 23, 2025

TriLink BioTechnologies® and Aldevron Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology
MRVI

Business Wire

18 days ago

TriLink BioTechnologies® and Aldevron Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology

MRVI

MT Newswires

20 days ago

Maravai LifeSciences' TriLink BioTechnologies Partners With Avantor to Expand Nucleic Acid Product Availability in EMEA

TriLink BioTechnologies® Partners with Avantor® to Expand Nucleic Acid Solutions in Europe
MRVI

Business Wire

20 days ago

TriLink BioTechnologies® Partners with Avantor® to Expand Nucleic Acid Solutions in Europe

MRVI

MT Newswires

25 days ago

Maravai Lifesciences Acquires Molecular Assemblies' Intellectual Property, Related Assets

Maravai LifeSciences Acquires Assets and Intellectual Property from Molecular Assemblies
MRVI

Business Wire

25 days ago

Maravai LifeSciences Acquires Assets and Intellectual Property from Molecular Assemblies

Three Top Undervalued Small Caps In US With Insider Buying
MRVI

Simply Wall St.

a month ago

Three Top Undervalued Small Caps In US With Insider Buying

Maravai LifeSciences Holdings, Inc. (MRVI) Stock: An Under $5 Gem with Biggest Upside Potential
MRVI

Insider Monkey

a month ago

Maravai LifeSciences Holdings, Inc. (MRVI) Stock: An Under $5 Gem with Biggest Upside Potential

MRVI

MT Newswires

a month ago

Maravai Lifesciences Reports Preliminary 2024 Revenue; Shares Fall After Hours

Maravai LifeSciences Announces Preliminary Unaudited 2024 Revenue
MRVI

GlobeNewswire

a month ago

Maravai LifeSciences Announces Preliminary Unaudited 2024 Revenue

Maravai Lifesciences initiated with a Neutral at Guggenheim
MRVI

TipRanks

2 months ago

Maravai Lifesciences initiated with a Neutral at Guggenheim

MRVI

MT Newswires

2 months ago

Guggenheim Initiates Coverage on Maravai Lifesciences With Neutral Rating

Exploring December 2024's Undervalued Small Caps With Insider Action In US
MRVI

Simply Wall St.

2 months ago

Exploring December 2024's Undervalued Small Caps With Insider Action In US

MRVI

MT Newswires

2 months ago

RBC Lowers Price Target on Maravai Lifesciences Holdings to $11 From $13, Keeps Outperform Rating

Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors
MRVI

GlobeNewswire

3 months ago

Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors

MRVI

MT Newswires

3 months ago

Goldman Sachs Downgrades Maravai Lifesciences to Sell From Neutral, Cuts Price Target to $4.25 From $7

Exploring ACNB And 2 More Undervalued Small Caps With Insider Buying In US
MRVI

Simply Wall St.

3 months ago

Exploring ACNB And 2 More Undervalued Small Caps With Insider Buying In US

MRVI

MT Newswires

3 months ago

Wolfe Research Initiates Maravai Lifesciences at Perform

Maravai LifeSciences Announces November 2024 Investor Conference Schedule
MRVI

GlobeNewswire

3 months ago

Maravai LifeSciences Announces November 2024 Investor Conference Schedule

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Just Reported Earnings, And Analysts Cut Their Target Price
MRVI

Simply Wall St.

3 months ago

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Just Reported Earnings, And Analysts Cut Their Target Price

Maravai Lifesciences price target lowered to $9 from $10 at Baird
MRVI

TipRanks

3 months ago

Maravai Lifesciences price target lowered to $9 from $10 at Baird

MRVI

Thomson Reuters StreetEvents

3 months ago

Q3 2024 Maravai LifeSciences Holdings Inc Earnings Call

MRVI

MT Newswires

3 months ago

Top Midday Decliners

MRVI

MT Newswires

3 months ago

UBS Adjusts Price Target on Maravai Lifesciences to $8 From $11, Maintains Neutral Rating

MRVI

MT Newswires

3 months ago

RBC Capital Adjusts Price Target on Maravai Lifesciences to $13 From $17, Maintains Outperform Rating

MRVI

MT Newswires

3 months ago

Maravai Lifesciences to Buy Officinae Bio's DNA, RNA Business

MRVI

MT Newswires

3 months ago

Maravai Lifesciences Shares Drop Pre-Bell After Q3 Loss, Revenue Miss Expectations, Lowered FY24 Guidance

MRVI

MT Newswires

3 months ago

William Blair Downgrades Maravai Lifesciences to Market Perform

Maravai LifeSciences Holdings Inc (MRVI) Q3 2024 Earnings Call Highlights: Navigating ...
MRVI

GuruFocus.com

3 months ago

Maravai LifeSciences Holdings Inc (MRVI) Q3 2024 Earnings Call Highlights: Navigating ...

Maravai LifeSciences Plans to Acquire DNA and RNA Business of Officinae Bio, Advancing Support for Innovative Nucleic Acid Research
MRVI

Business Wire

3 months ago

Maravai LifeSciences Plans to Acquire DNA and RNA Business of Officinae Bio, Advancing Support for Innovative Nucleic Acid Research

Maravai LifeSciences Reports Third Quarter 2024 Financial Results
MRVI

GlobeNewswire

3 months ago

Maravai LifeSciences Reports Third Quarter 2024 Financial Results

Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 7, 2024
MRVI

GlobeNewswire

4 months ago

Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 7, 2024

RGA Investment Advisors Highlights Maravai LifeSciences Holdings, Inc. (MRVI) in Q1 2024 Letter
MRVI

Insider Monkey

4 months ago

RGA Investment Advisors Highlights Maravai LifeSciences Holdings, Inc. (MRVI) in Q1 2024 Letter

TriLink BioTechnologies® & Alphazyme Collaborate to Launch New CleanScribe™ RNA Polymerase
MRVI

Business Wire

5 months ago

TriLink BioTechnologies® & Alphazyme Collaborate to Launch New CleanScribe™ RNA Polymerase

Maravai LifeSciences' Cygnus & TriLink Unveil AccuRes DNA Kits
MRVI

Zacks

6 months ago

Maravai LifeSciences' Cygnus & TriLink Unveil AccuRes DNA Kits

MRVI

MT Newswires

6 months ago

Maravai LifeSciences Units Launch AccuRes Host Cell DNA Quantification Kits

Cygnus Technologies and TriLink BioTechnologies® Collaborate to Launch AccuRes™ Host Cell DNA Quantification Kits
MRVI

Business Wire

6 months ago

Cygnus Technologies and TriLink BioTechnologies® Collaborate to Launch AccuRes™ Host Cell DNA Quantification Kits

MRVI

MT Newswires

6 months ago

Wells Fargo Initiates Maravai LifeSciences at Overweight With $10 Price Target

MRVI

MT Newswires

6 months ago

Market Chatter: Maravai LifeSciences Receives Acquisition Offer From Repligen

MRVI

MT Newswires

6 months ago

Morgan Stanley Downgrades Maravai LifeSciences to Equalweight From Overweight, Adjusts Price Target to $10 From $11

Maravai LifeSciences Announces August and September 2024 Investor Conference Schedule
MRVI

GlobeNewswire

6 months ago

Maravai LifeSciences Announces August and September 2024 Investor Conference Schedule

MRVI

MT Newswires

6 months ago

UBS Adjusts Maravai LifeSciences Holdings Price Target to $11 From $8.50, Maintains Neutral Rating

Maravai LifeSciences (MRVI) Q2 2024 Earnings Call Transcript
MRVI

Motley Fool

6 months ago

Maravai LifeSciences (MRVI) Q2 2024 Earnings Call Transcript

Maravai LifeSciences Reports Second Quarter 2024 Financial Results
MRVI

GlobeNewswire

6 months ago

Maravai LifeSciences Reports Second Quarter 2024 Financial Results

Maravai LifeSciences Appoints Trey Martin to Board of Directors
MRVI

GlobeNewswire

7 months ago

Maravai LifeSciences Appoints Trey Martin to Board of Directors

Maravai LifeSciences To Host Earnings Conference Call on Wednesday, August 7, 2024
MRVI

GlobeNewswire

7 months ago

Maravai LifeSciences To Host Earnings Conference Call on Wednesday, August 7, 2024

MRVI

MT Newswires

7 months ago

Goldman Sachs Trims Price Target on Maravai LifeSciences to $7 From $8, Maintains Neutral Rating

Maravai Lifesciences Releases 2023 Environmental, Social and Governance (ESG) Report
MRVI

GlobeNewswire

8 months ago

Maravai Lifesciences Releases 2023 Environmental, Social and Governance (ESG) Report

Here’s Why RGAIA Considers Maravai LifeSciences Holdings’ (MRVI) Margin Structure as the Best
MRVI

Insider Monkey

8 months ago

Here’s Why RGAIA Considers Maravai LifeSciences Holdings’ (MRVI) Margin Structure as the Best

Steven Cohen's Strategic Acquisition in Maravai LifeSciences Holdings Inc
MRVI

GuruFocus.com

8 months ago

Steven Cohen's Strategic Acquisition in Maravai LifeSciences Holdings Inc

HEATHERWICK STUDIO UNVEILS ICONIC GLASS CANOPY, THE JEWEL IN THE CROWN OF REIMAGINED OLYMPIA
MRVI

CNW Group

8 months ago

HEATHERWICK STUDIO UNVEILS ICONIC GLASS CANOPY, THE JEWEL IN THE CROWN OF REIMAGINED OLYMPIA

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku
MRVI

CNW Group

8 months ago

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse
MRVI

PR Newswire

8 months ago

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store
MRVI

Business Wire

8 months ago

Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store

New Zealand scraps plan to tax livestock burps, farts
MRVI

AFP

8 months ago

New Zealand scraps plan to tax livestock burps, farts

MRVI

Business Wire

8 months ago

InnoCare Announces Clearance of Clinical Trial of TYK2 Inhibitor ICP-332 by U.S. FDA

ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility
MRVI

The Wall Street Journal

8 months ago

ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility

UK Unemployment Rises in Sign Inflationary Pressures Cool
MRVI

Bloomberg

8 months ago

UK Unemployment Rises in Sign Inflationary Pressures Cool

Lotto 6/49 - $64 million up for grabs in the next draw!
MRVI

CNW Group

8 months ago

Lotto 6/49 - $64 million up for grabs in the next draw!

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture
MRVI

Simply Wall St.

8 months ago

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Seoul says it will resume loudspeaker propaganda against North
MRVI

AFP

8 months ago

Seoul says it will resume loudspeaker propaganda against North

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend
MRVI

Simply Wall St.

8 months ago

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m
MRVI

Simply Wall St.

8 months ago

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week
MRVI

Barrons.com

8 months ago

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend
MRVI

Simply Wall St.

8 months ago

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued
MRVI

Simply Wall St.

8 months ago

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Industry Report: The Cannabis Company that Soared Nearly 100% This Year: What's Behind InterCure's Surge
MRVI

ACCESSWIRE

8 months ago

Industry Report: The Cannabis Company that Soared Nearly 100% This Year: What's Behind InterCure's Surge

Russia is doubling down on its de-dollarization efforts as Putin calls to reduce use of 'toxic' currencies
MRVI

Business Insider

8 months ago

Russia is doubling down on its de-dollarization efforts as Putin calls to reduce use of 'toxic' currencies

4DMT Presents Injection-Free Subgroup Analyses from 4D-150 Phase 2 PRISM Randomized Dose Expansion Cohort in Wet AMD Patients with Severe Disease Activity & High Treatment Burden at the Clinical Trials at the Summit 2024 Meeting
MRVI

GlobeNewswire

8 months ago

4DMT Presents Injection-Free Subgroup Analyses from 4D-150 Phase 2 PRISM Randomized Dose Expansion Cohort in Wet AMD Patients with Severe Disease Activity & High Treatment Burden at the Clinical Trials at the Summit 2024 Meeting

Nvidia May Be an Exciting Stock, but Its 10-for-1 Stock Split -- Like Most Stock Splits -- Is a Nothing Burger
MRVI

Motley Fool

8 months ago

Nvidia May Be an Exciting Stock, but Its 10-for-1 Stock Split -- Like Most Stock Splits -- Is a Nothing Burger

Unifor members vote to strike at Manitoba Hydro
MRVI

CNW Group

8 months ago

Unifor members vote to strike at Manitoba Hydro

Croatia beat Portugal in Euro 2024 warm-up friendly
MRVI

AFP

8 months ago

Croatia beat Portugal in Euro 2024 warm-up friendly

Mark Cuban explains how he helped turn 300 of his employees into millionaires
MRVI

Business Insider

8 months ago

Mark Cuban explains how he helped turn 300 of his employees into millionaires

Here's what to do if you missed out on the massive 54% stock market rally since October 2022
MRVI

Business Insider

8 months ago

Here's what to do if you missed out on the massive 54% stock market rally since October 2022

Maravai (MRVI) Advances in RNA Research With New Collaboration
MRVI

Zacks

9 months ago

Maravai (MRVI) Advances in RNA Research With New Collaboration

TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center
MRVI

Business Wire

9 months ago

TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center

Maravai LifeSciences Holdings First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
MRVI

Simply Wall St.

9 months ago

Maravai LifeSciences Holdings First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q1 2024 Earnings Call Transcript
MRVI

Insider Monkey

9 months ago

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q1 2024 Earnings Call Transcript

Maravai LifeSciences Announces May and June 2024 Investor Conference Schedule
MRVI

GlobeNewswire

9 months ago

Maravai LifeSciences Announces May and June 2024 Investor Conference Schedule

MRVI

MT Newswires

9 months ago

UBS Raises Price Target on Maravai LifeSciences to $8.50 From $6.50, Maintains Neutral Rating

MRVI

MT Newswires

9 months ago

Baird Adjusts Price Target on Maravai LifeSciences to $10 From $8, Keeps Outperform Rating

MRVI

GuruFocus.com

9 months ago

Maravai LifeSciences Holdings Inc (MRVI) (Q1 2024) Earnings Call Transcript Highlights: ...

Maravai LifeSciences (MRVI) Q1 2024 Earnings Call Transcript
MRVI

Motley Fool

9 months ago

Maravai LifeSciences (MRVI) Q1 2024 Earnings Call Transcript

Maravai LifeSciences Reports First Quarter 2024 Financial Results
MRVI

GlobeNewswire

9 months ago

Maravai LifeSciences Reports First Quarter 2024 Financial Results

TriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology
MRVI

Business Wire

10 months ago

TriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology

TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production
MRVI

Business Wire

10 months ago

TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production

Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024
MRVI

GlobeNewswire

10 months ago

Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024

Should You Sell Maravai LifeSciences (MRVI)?
MRVI

Insider Monkey

a year ago

Should You Sell Maravai LifeSciences (MRVI)?

Maravai LifeSciences Announces March 2024 Investor Conference Schedule
MRVI

GlobeNewswire

a year ago

Maravai LifeSciences Announces March 2024 Investor Conference Schedule

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Just Released Its Annual Results And Analysts Are Updating Their Estimates
MRVI

Simply Wall St.

a year ago

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Just Released Its Annual Results And Analysts Are Updating Their Estimates

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q4 2023 Earnings Call Transcript
MRVI

Insider Monkey

a year ago

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q4 2023 Earnings Call Transcript

MRVI

Thomson Reuters StreetEvents

a year ago

Q4 2023 Maravai LifeSciences Holdings Inc Earnings Call

Maravai LifeSciences (MRVI) Q4 2023 Earnings Call Transcript
MRVI

Motley Fool

a year ago

Maravai LifeSciences (MRVI) Q4 2023 Earnings Call Transcript

Maravai LifeSciences Holdings Inc (MRVI) Faces Net Loss in 2023 Despite Revenue Outperformance
MRVI

GuruFocus.com

a year ago

Maravai LifeSciences Holdings Inc (MRVI) Faces Net Loss in 2023 Despite Revenue Outperformance

Maravai LifeSciences Reports Fourth Quarter and Full Year 2023 Financial Results
MRVI

GlobeNewswire

a year ago

Maravai LifeSciences Reports Fourth Quarter and Full Year 2023 Financial Results

TriLink BioTechnologies® Solidifies IP Position with Awarded Patents for CleanCap® Capping Technology in China and Canada
MRVI

Business Wire

a year ago

TriLink BioTechnologies® Solidifies IP Position with Awarded Patents for CleanCap® Capping Technology in China and Canada

Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality Assurance in Biomanufacturing
MRVI

GlobeNewswire

a year ago

Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality Assurance in Biomanufacturing

3 Doomed Biotech Stocks to Dump Before They Dive: February 2024
MRVI

InvestorPlace

a year ago

3 Doomed Biotech Stocks to Dump Before They Dive: February 2024

Will Maravai LifeSciences Holdings (MRVI) Pipeline Start to Bear Fruit?
MRVI

Insider Monkey

a year ago

Will Maravai LifeSciences Holdings (MRVI) Pipeline Start to Bear Fruit?

Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
MRVI

Simply Wall St.

a year ago

Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

MRVI

Thomson Reuters StreetEvents

a year ago

Q1 2024 Leslie's Inc Earnings Call

Share on Social Networks: